Bilberry (25% anthocyanins).

A 25 percent anthocyanin extract delivers water-soluble flavonoids that stay in the aqueous phase, while lutein is a lipid-soluble carotenoid that deposits in macular pigment and absorbs short-wavelength light. Each covers a compartment the other does not.

Zeaxanthin concentrates in the central macula and absorbs high-energy visible light, a filtering role anthocyanins do not perform. Standardised bilberry anthocyanins add water-phase radical scavenging, so the two are additive rather than interchangeable.

Ascorbate reduces oxidised anthocyanin radicals back to their active form and the anthocyanins spare ascorbate in return, standard flavonoid and vitamin C recycling chemistry. Vitamin C is separately required as the cofactor for collagen hydroxylation.

Vitamin E breaks lipid peroxidation chains inside cell membranes, where water-soluble anthocyanins do not partition. Its spent tocopheroxyl radical is regenerated by the aqueous antioxidant pool that polyphenols and ascorbate support.

A high standardised anthocyanin load binds more non-heme iron in the gut lumen, lowering the absorbed fraction. Separating doses is the usual handling.

Both are glucuronidated by the same enzymes on first pass, so a standardised high anthocyanin dose competes with quercetin for that capacity.

Piperine inhibits intestinal UGT activity, so more anthocyanin metabolite escapes first-pass conjugation. Circulating exposure rises for the same oral dose.

Anthocyanins are absorbed poorly as intact glycosides, and most of what a person actually circulates are microbial metabolites such as protocatechuic acid formed in the colon. Response to anthocyanin supplementation differed by gut enterotype in a supplementation study. Which bacteria a person carries plausibly changes what a bilberry dose becomes.

Anthocyanins depend on colonic bacteria for the deglycosylation and ring fission that produce their absorbable metabolites. A fermentable fibre feeds the same community. The reasoning is mechanistic. No trial has paired a bilberry extract with a specific prebiotic.

Docosahexaenoic acid is the dominant fatty acid of photoreceptor outer segment membranes, a structural role, while anthocyanins act on capillary and redox chemistry in the same tissue. The two work on different parts of normal visual function. They are commonly formulated together for that reason, not because a combination has been measured.

Astaxanthin is a lipid-phase xanthophyll and anthocyanins act in the aqueous phase, so the two cover different compartments of the same redox chemistry. Both appear in eye-support formulas. Combination data in people is absent.

Taurine is present in retinal tissue at high concentration and supports normal photoreceptor structure, a distinct role from the vascular and antioxidant reasoning behind anthocyanins. Formulators pair them to cover both. The pairing rests on separate mechanisms rather than on a trial.

Retinal, derived from vitamin A, is the chromophore that regenerates rhodopsin after light exposure, and adequate vitamin A is a hard requirement for that cycle. Bilberry's traditional night-vision reputation is often explained by an effect on rhodopsin regeneration, which remains a proposed mechanism rather than a demonstrated one. Vitamin A's role in the cycle is settled. Bilberry's is not.

Zinc is a cofactor for retinol dehydrogenase and is concentrated in retinal tissue, which is why it appears in almost every vision formula. Anthocyanins contribute a different, vascular and antioxidant, rationale. Note that concentrated plant polyphenols can also bind divalent minerals in the gut, so timing matters when both are in the same capsule.

Sustained higher zinc intakes lower copper absorption by inducing intestinal metallothionein, which is why copper is added alongside zinc in vision blends. The relationship is with the zinc in the formula rather than with the bilberry. It is included here because bilberry products so often carry that mineral pair.

Both are flavonoid-rich botanicals used on a microcirculatory rationale, ginkgo through flavone glycosides and terpene lactones and bilberry through anthocyanins. Combining them stacks two agents with mild effects on platelet behaviour, which is worth flagging for anyone already on blood-thinning medication. No combination trial exists.

Rutin and the citrus bioflavonoids have been paired with anthocyanins in capillary-support formulations for decades, on a shared rationale about small-vessel wall integrity. The convention is long-standing and the human evidence for the combination is thin. It belongs in the formulation-history column.

Grape seed proanthocyanidins and bilberry anthocyanins are two branches of the same flavonoid family and share both absorption limits and microbial catabolism. Together they broaden the polyphenol profile in a capsule. They also compete for the same conjugation enzymes, so more polyphenol does not scale linearly into more circulating metabolite.

Pine bark procyanidins and bilberry anthocyanins are both used on vascular and capillary rationales and both are studied for effects on endothelial markers. The pairing is common in eye and circulation formulas. Markers are what the literature reports here, not clinical outcomes.

Elderberry is another concentrated anthocyanin source, dominated by cyanidin glycosides where bilberry carries a broader mix of delphinidin, cyanidin, malvidin, petunidin and peonidin glycosides. Blending them raises total anthocyanin without changing the class. It also makes analytical identity harder, which matters because anthocyanin extracts are a known adulteration target.

Both are grape and berry polyphenols acting on Nrf2-linked antioxidant response signalling in cell models. The overlap is at the signalling level rather than at a shared target. Human combination data does not exist.

Curcumin and anthocyanin supplementation were given together in a randomised presurgical study that measured inflammatory and metabolic blood markers. Marker movement is not a clinical outcome, and a combination design cannot attribute any change to one of the two. It is nevertheless a genuine co-administration study rather than an inferred pairing.

Lipoic acid works in both the aqueous and lipid phases and participates in regenerating other antioxidants, which is the standard rationale for adding it to a polyphenol formula. Whether that recycling chemistry meaningfully extends anthocyanin activity in people has not been shown. Confidence sits at the lowest band.

Milk proteins bind anthocyanins and other polyphenols, and taking a berry extract with milk or a casein shake lowers the free polyphenol measured afterwards. The binding is well described in food chemistry. What it means for a final effect is less settled, which is why the confidence is not higher.

Glutathione reductase is a flavin-dependent enzyme, so riboflavin status sets how fast oxidised glutathione is recycled. Anthocyanins feed into the same broad redox network from the other side. This is settled cofactor biochemistry rather than a berry-specific interaction.